Myofascial Pain Syndrome and Plantar Fasciitis Treatment
Plantar Fascitis, Myofascial Pain Syndrome
About this trial
This is an interventional treatment trial for Plantar Fascitis focused on measuring plantar fasciitis, ESWT, dry needling
Eligibility Criteria
Inclusion Criteria: Patients aged 25-65 years with heel pain for more than 6 weeks tenderness on palpation in the medial calcaneal region aggravation of symptoms while standing and in the first hours of the morning who agreed not to receive anti-inflammatory treatment during the study period fascia thickness >4mm measured by ultrasound. Exclusion Criteria: Patients diagnosed with rheumatologic diseases Those diagnosed with Diabetes Mellitus (DM), those with chronic liver and kidney failure Anti-inflammatory-analgesic treatment within the last 1 month Diagnosed with inflammatory rheumatic disease Those with a history of foot surgery Those with mid or hindfoot deformity Previous history of central or peripheral nerve damage, lower extremity neuropathy Those diagnosed with Diabetes Mellitus Those with cognitive impairment Unassisted mobilization Those with bleeding disorders Pregnant women
Sites / Locations
- Istanbul Training and Resarch Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
group 1: ESWT treatment
Dry needling
Participants in this group will only receive ESWT treatment
Participants in this group will only receive Dry needling treatment